Biomaterials Market by Type (Metallic, Polymeric, Ceramic, and Natural) and Application, (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders, and Drug Delivery Systems): Global Opportunity Analysis and Industry Forecast, 2021–2030
The global biomaterials market was valued at $64,874 million in 2020 and is projected to reach $2,12,405.2 million by 2030, registering a CAGR of 12.7% from 2021 to 2030.
Biomaterial is a groundbreaking technological innovation of medical technology that can enhance the functionalities of damaged tissues or organs. Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devices, skin repair, heart valves, and other medical implants. The recent success in the usage of biomaterials witnessed in the fields of cardiovascular medicine, immunology, orthopedics, dental medicine, infection, and ophthalmology opens new avenues for biomaterials technology.
The main factors that drive the growth of the biomaterials market include, increase in geriatric population, rise in prevalence rates of cardiovascular & orthopedic disorders, advancement in medical technology, and increase in awareness regarding implantable devices. In addition, increase in funding by government to increase R&D activities in the field of biomaterials and increase in awareness about the advantages of biomaterials products further drive the growth of the market. However, high cost of biomaterial implants and compatibility issues are expected to hamper the market growth. On the other hand, introduction of new technologies, namely, decellularized dermal matrixes for grafting and hydrogen scaffolding, and launch of new products in field of plastic surgery, wound healing, and neurology profitable opportunities for the growth of the market during the forecast period.
The biomaterial market is segmented on the basis of type, application, and region to provide a detailed assessment of the market. By type, the market is segmented into metallic, polymeric, ceramic, and natural. Metallic biomaterials are again segmented into stainless steel, titanium & titanium alloys, cobalt-chrome alloys, gold, and silver. In addition, polymeric biomaterials are again divided into polymethyl methacrylate (PMMA), polyethylene, polyester, polyvinylchloride, silicone rubber, nylon, and polyetheretherketone. Furthermore, ceramic biomaterials are again bifurcated into calcium phosphate, zirconia, aluminum oxide, calcium sulfate, carbon, and glass. Moreover, natural biomaterials sub segmented into hyaluronic acid, collagen & gelatin, fibrin, cellulose, chitin, alginates, and silk.
On the basis of application, the market is classified into cardiovascular, dental, orthopedic, wound healing, plastic surgery, ophthalmology, tissue engineering, neurological disorders, and drug delivery systems. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key market players profiled in the report include Carpenter Technology Corporation, Corbion N.V, Covalon Technologies Ltd., Evonik Industries, Linden Capital Partners (Collagen Matrix, Inc.), Noble Biomaterials Inc., Royal DSM, Victrex plc., Stryker Corporation (Wright Medical Group N.V), and Zimmer Biomet Holdings, Inc.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global biomaterials market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps to understand the application and products of biomaterials used across the globe.
Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
By Type
Metallic
Stainless Steel
Titanium & Titanium Alloys
Cobalt-Chrome Alloys
Gold
Silver
Polymeric
Polymethylmethacrylate (PMMA)
Polyethylene
Polyester
Polyvinylchloride
Silicone Rubber
Nylon
Polyetheretherketone
Ceramic
Calcium Phosphate
Zirconia
Aluminum Oxide
Calcium Sulfate
carbon
Glass
Natural
Hyaluronic Acid
Collagen & Gelatin
Fibrin
Cellulose
Chitin
Alginates
Silk
By Application
Cardiovascular
Dental
Orthopedic
Wound Healing
Plastic Surgery
Ophthalmology
Neurological Disorder
Drug Delivery System
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
Carpenter Technology Corporation
Corbion N.V
Covalon Technologies Ltd.
Evonik Industries
Linden Capital Partners (Collagen Matrix, Inc.)
Noble Biomaterials Inc.
Royal DSM
Victrex plc
Stryker Corporation (Wright Medical Group N.V)
Zimmer Biomet Holdings,
- CHAPTER 1: INTRODUCTION
- 1.1.Report Description
- 1.2.Key Market Segments
- 1.3.Key Benefits
- 1.4.Research Methodology
- 1.4.1.Primary Research
- 1.4.2.Secondary Research
- 1.4.3.Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1.CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1.Market Definition and Scope
- 3.2.Key Findings
- 3.2.1.Top Investment Pockets
- 3.2.2.Top Winning Strategies
- 3.3.Porter's Five Forces Analysis
- 3.3.1.Bargaining Power of Suppliers
- 3.3.2.Threat of New Entrants
- 3.3.3.Threat of Substitutes
- 3.3.4.Competitive Rivalry
- 3.3.5.Bargaining Power among Buyers
- 3.4.Market Share Analysis/Top Player Positioning
- 3.4.1.Market Share Analysis/Top Player Positioning 2020
- 3.5.Market Dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6. COVID-19 Impact Analysis
- CHAPTER 4: BIOMATERIALS MARKET, BY TYPE
- 4.1.Market Overview
- 4.1.1Market Size and Forecast, By Type
- 4.2.Metallic
- 4.2.1.Key Market Trends, Growth Factors and Opportunities
- 4.2.2.Market Size and Forecast, By Region
- 4.2.3.Market Share Analysis, By Country
- 4.2.4.Stainless Steel
- 4.2.4.1.Market Size and Forecast
- 4.2.5.Titanium and Titanium Alloys
- 4.2.5.1.Market Size and Forecast
- 4.2.6.Cobalt-Chrome Alloys
- 4.2.6.1.Market Size and Forecast
- 4.2.7.Gold
- 4.2.7.1.Market Size and Forecast
- 4.2.8.Silver
- 4.2.8.1.Market Size and Forecast
- 4.3.Polymeric
- 4.3.1.Key Market Trends, Growth Factors and Opportunities
- 4.3.2.Market Size and Forecast, By Region
- 4.3.3.Market Share Analysis, By Country
- 4.3.4.Polymethylmethacrylate
- 4.3.4.1.Market Size and Forecast
- 4.3.5.Polyethylene
- 4.3.5.1.Market Size and Forecast
- 4.3.6.Polyester
- 4.3.6.1.Market Size and Forecast
- 4.3.7.Polyvinylchloride
- 4.3.7.1.Market Size and Forecast
- 4.3.8.Silicone Rubber
- 4.3.8.1.Market Size and Forecast
- 4.3.9.Nylon
- 4.3.9.1.Market Size and Forecast
- 4.3.10.Polyetheretherketone
- 4.3.10.1.Market Size and Forecast
- 4.4.Ceramic
- 4.4.1.Key Market Trends, Growth Factors and Opportunities
- 4.4.2.Market Size and Forecast, By Region
- 4.4.3.Market Share Analysis, By Country
- 4.4.4.Calcium Phosphate
- 4.4.4.1.Market Size and Forecast
- 4.4.5.Zirconia
- 4.4.5.1.Market Size and Forecast
- 4.4.6.Aluminum Oxide
- 4.4.6.1.Market Size and Forecast
- 4.4.7.Calcium Sulfate
- 4.4.7.1.Market Size and Forecast
- 4.4.8.Carbon
- 4.4.8.1.Market Size and Forecast
- 4.4.9.Glass
- 4.4.9.1.Market Size and Forecast
- 4.5.Natural
- 4.5.1.Key Market Trends, Growth Factors and Opportunities
- 4.5.2.Market Size and Forecast, By Region
- 4.5.3.Market Share Analysis, By Country
- 4.5.4.Hyaluronic Acid
- 4.5.4.1.Market Size and Forecast
- 4.5.5.Collagen and Gelatin
- 4.5.5.1.Market Size and Forecast
- 4.5.6.Fibrin
- 4.5.6.1.Market Size and Forecast
- 4.5.7.Cellulose
- 4.5.7.1.Market Size and Forecast
- 4.5.8.Chitin
- 4.5.8.1.Market Size and Forecast
- 4.5.9.Alginates
- 4.5.9.1.Market Size and Forecast
- 4.5.10.Silk
- 4.5.10.1.Market Size and Forecast
- CHAPTER 5: BIOMATERIALS MARKET, BY APPLICATION
- 5.1.Market Overview
- 5.1.1Market Size and Forecast, By Application
- 5.2.Cardiovascular
- 5.2.1.Market Size and Forecast, By Region
- 5.2.2.Market Share Analysis, By Country
- 5.3.Dental
- 5.3.1.Market Size and Forecast, By Region
- 5.3.2.Market Share Analysis, By Country
- 5.4.Orthopedic
- 5.4.1.Market Size and Forecast, By Region
- 5.4.2.Market Share Analysis, By Country
- 5.5.Wound Healing
- 5.5.1.Market Size and Forecast, By Region
- 5.5.2.Market Share Analysis, By Country
- 5.6.Plastic Surgery
- 5.6.1.Market Size and Forecast, By Region
- 5.6.1.Market Share Analysis, By Country
- 5.7.Ophthalmology
- 5.7.1.Market Size and Forecast, By Region
- 5.7.2.Market Share Analysis, By Country
- 5.8.Neurological Disorder
- 5.8.1.Market Size and Forecast, By Region
- 5.8.2.Market Share Analysis, By Country
- 5.9.Drug Delivery System
- 5.9.1.Market Size and Forecast, By Region
- 5.9.2.Market Share Analysis, By Country
- CHAPTER 6: BIOMATERIALS MARKET, BY REGION
- 6.1.Market Overview
- 6.1.1Market Size and Forecast, By Region
- 6.2.North America
- 6.2.1.Key Market Trends and Opportunities
- 6.2.2.Market Size and Forecast, By Type
- 6.2.3.Market Size and Forecast, By Application
- 6.2.4.Market Size and Forecast, By Country
- 6.2.5.United States Biomaterials Market
- 6.2.5.1.Market Size and Forecast, By Type
- 6.2.5.2.Market Size and Forecast, By Application
- 6.2.6.Canada Biomaterials Market
- 6.2.6.1.Market Size and Forecast, By Type
- 6.2.6.2.Market Size and Forecast, By Application
- 6.2.7.Mexico Biomaterials Market
- 6.2.7.1.Market Size and Forecast, By Type
- 6.2.7.2.Market Size and Forecast, By Application
- 6.3.Europe
- 6.3.1.Key Market Trends and Opportunities
- 6.3.2.Market Size and Forecast, By Type
- 6.3.3.Market Size and Forecast, By Application
- 6.3.4.Market Size and Forecast, By Country
- 6.3.5.Germany Biomaterials Market
- 6.3.5.1.Market Size and Forecast, By Type
- 6.3.5.2.Market Size and Forecast, By Application
- 6.3.6.UK Biomaterials Market
- 6.3.6.1.Market Size and Forecast, By Type
- 6.3.6.2.Market Size and Forecast, By Application
- 6.3.7.France Biomaterials Market
- 6.3.7.1.Market Size and Forecast, By Type
- 6.3.7.2.Market Size and Forecast, By Application
- 6.3.8.Italy Biomaterials Market
- 6.3.8.1.Market Size and Forecast, By Type
- 6.3.8.2.Market Size and Forecast, By Application
- 6.3.9.Spain Biomaterials Market
- 6.3.9.1.Market Size and Forecast, By Type
- 6.3.9.2.Market Size and Forecast, By Application
- 6.3.10.Rest Of Europe Biomaterials Market
- 6.3.10.1.Market Size and Forecast, By Type
- 6.3.10.2.Market Size and Forecast, By Application
- 6.4.Asia-Pacific
- 6.4.1.Key Market Trends and Opportunities
- 6.4.2.Market Size and Forecast, By Type
- 6.4.3.Market Size and Forecast, By Application
- 6.4.4.Market Size and Forecast, By Country
- 6.4.5.Japan Biomaterials Market
- 6.4.5.1.Market Size and Forecast, By Type
- 6.4.5.2.Market Size and Forecast, By Application
- 6.4.6.China Biomaterials Market
- 6.4.6.1.Market Size and Forecast, By Type
- 6.4.6.2.Market Size and Forecast, By Application
- 6.4.7.India Biomaterials Market
- 6.4.7.1.Market Size and Forecast, By Type
- 6.4.7.2.Market Size and Forecast, By Application
- 6.4.8.Australia Biomaterials Market
- 6.4.8.1.Market Size and Forecast, By Type
- 6.4.8.2.Market Size and Forecast, By Application
- 6.4.9.South Korea Biomaterials Market
- 6.4.9.1.Market Size and Forecast, By Type
- 6.4.9.2.Market Size and Forecast, By Application
- 6.4.10.Rest Of Asia-pacific Biomaterials Market
- 6.4.10.1.Market Size and Forecast, By Type
- 6.4.10.2.Market Size and Forecast, By Application
- 6.5.LAMEA
- 6.5.1.Key Market Trends and Opportunities
- 6.5.2.Market Size and Forecast, By Type
- 6.5.3.Market Size and Forecast, By Application
- 6.5.4.Market Size and Forecast, By Country
- 6.5.5.Brazil Biomaterials Market
- 6.5.5.1.Market Size and Forecast, By Type
- 6.5.5.2.Market Size and Forecast, By Application
- 6.5.6.Saudi Arabia Biomaterials Market
- 6.5.6.1.Market Size and Forecast, By Type
- 6.5.6.2.Market Size and Forecast, By Application
- 6.5.7.South Africa Biomaterials Market
- 6.5.7.1.Market Size and Forecast, By Type
- 6.5.7.2.Market Size and Forecast, By Application
- 6.5.8.Rest of LAMEA Biomaterials Market
- 6.5.8.1.Market Size and Forecast, By Type
- 6.5.8.2.Market Size and Forecast, By Application
- CHAPTER 7: COMPANY PROFILES
- 7.1.Carpenter Technology Corporation
- 7.1.1.Company Overview
- 7.1.2.Company snapshot
- 7.1.3.Operating business segments
- 7.1.4.Product portfolio
- 7.1.5.Business Performance
- 7.2.Corbion N.V
- 7.2.1.Company Overview
- 7.2.2.Company snapshot
- 7.2.3.Operating business segments
- 7.2.4.Product portfolio
- 7.2.5.Business Performance
- 7.3.Covalon Technologies Ltd.
- 7.3.1.Company Overview
- 7.3.2.Key Executives
- 7.3.3.Company snapshot
- 7.3.4.Operating business segments
- 7.3.5.Product portfolio
- 7.3.6.Business Performance
- 7.3.7.Key Strategic Moves and Developments
- 7.4.Evonik Industries
- 7.4.1.Company Overview
- 7.4.2.Company snapshot
- 7.4.3.Operating business segments
- 7.4.4.Product portfolio
- 7.4.5.Business Performance
- 7.4.6.Key Strategic Moves and Developments
- 7.5.Linden Capital Partners (Collagen Matrix, Inc.)
- 7.5.1.Company Overview
- 7.5.2.Company snapshot
- 7.5.3.Operating business segments
- 7.5.4.Product portfolio
- 7.6.Noble Biomaterials Inc.
- 7.6.1.Company Overview
- 7.6.2.Company snapshot
- 7.6.3.Operating business segments
- 7.6.4.Product portfolio
- 7.7.Royal DSM
- 7.7.1.Company Overview
- 7.7.2.Company snapshot
- 7.7.3.Operating business segments
- 7.7.4.Product portfolio
- 7.7.5.Business Performance
- 7.7.6.Key Strategic Moves and Developments
- 7.8.Victrex Plc
- 7.8.1.Company Overview
- 7.8.2.Company snapshot
- 7.8.3.Operating business segments
- 7.8.4.Product portfolio
- 7.8.5.Business Performance
- 7.9.Stryker Corporation (Wright Medical Group N.V)
- 7.9.1.Company Overview
- 7.9.2.Company snapshot
- 7.9.3.Operating business segments
- 7.9.4.Product portfolio
- 7.9.5.Business Performance
- 7.9.6.Key Strategic Moves and Developments
- 7.10.Zimmer Biomet Holdings, Inc.
- 7.10.1.Company Overview
- 7.10.2.Company snapshot
- 7.10.3.Operating business segments
- 7.10.4.Product portfolio
- 7.10.5.Business Performance
- LIST OF TABLES
- TABLE 1.GLOBAL BIOMATERIALS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 2.GLOBAL BIOMATERIALS MARKET FOR METALLIC, BY REGION, 2020-2030 ($MILLION)
- TABLE 3.GLOBAL BIOMATERIALS MARKET FOR POLYMERIC, BY REGION, 2020-2030 ($MILLION)
- TABLE 4.GLOBAL BIOMATERIALS MARKET FOR CERAMIC, BY REGION, 2020-2030 ($MILLION)
- TABLE 5.GLOBAL BIOMATERIALS MARKET FOR NATURAL, BY REGION, 2020-2030 ($MILLION)
- TABLE 6.GLOBAL BIOMATERIALS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 7.GLOBAL BIOMATERIALS MARKET FOR CARDIOVASCULAR, BY REGION, 2020-2030 ($MILLION)
- TABLE 8.GLOBAL BIOMATERIALS MARKET FOR DENTAL, BY REGION, 2020-2030 ($MILLION)
- TABLE 9.GLOBAL BIOMATERIALS MARKET FOR ORTHOPEDIC, BY REGION, 2020-2030 ($MILLION)
- TABLE 10.GLOBAL BIOMATERIALS MARKET FOR WOUND HEALING, BY REGION, 2020-2030 ($MILLION)
- TABLE 11.GLOBAL BIOMATERIALS MARKET FOR PLASTIC SURGERY, BY REGION, 2020-2030 ($MILLION)
- TABLE 12.GLOBAL BIOMATERIALS MARKET FOR OPHTHALMOLOGY, BY REGION, 2020-2030 ($MILLION)
- TABLE 13.GLOBAL BIOMATERIALS MARKET FOR NEUROLOGICAL DISORDER, BY REGION, 2020-2030 ($MILLION)
- TABLE 14.GLOBAL BIOMATERIALS MARKET FOR DRUG DELIVERY SYSTEM, BY REGION, 2020-2030 ($MILLION)
- TABLE 15.GLOBAL BIOMATERIALS MARKET, BY REGION, 2020-2030 ($MILLION)
- TABLE 16.NORTH AMERICA BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 17.NORTH AMERICA BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 18.UNITED STATES BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 19.UNITED STATES BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 20.CANADA BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 21.CANADA BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 22.MEXICO BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 23.MEXICO BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 24.EUROPE BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 25.EUROPE BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 26.GERMANY BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 27.GERMANY BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 28.UK BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 29.UK BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 30.FRANCE BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 31.FRANCE BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 32.ITALY BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 33.ITALY BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 34.SPAIN BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 35.SPAIN BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 36.REST OF EUROPE BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 37.REST OF EUROPE BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 38.ASIA-PACIFIC BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 39.ASIA-PACIFIC BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 40.JAPAN BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 41.JAPAN BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 42.CHINA BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 43.CHINA BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 44.INDIA BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 45.INDIA BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 46.AUSTRALIA BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 47.AUSTRALIA BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 48.SOUTH KOREA BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 49.SOUTH KOREA BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 50.REST OF ASIA-PACIFIC BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 51.REST OF ASIA-PACIFIC BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 52.LAMEA BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 53.LAMEA BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 54.BRAZIL BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 55.BRAZIL BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 56.SAUDI ARABIA BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 57.SAUDI ARABIA BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 58.SOUTH AFRICA BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 59.SOUTH AFRICA BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 60.REST OF LAMEA BIOMATERIALS, BY TYPE, 2020-2030 ($MILLION)
- TABLE 61.REST OF LAMEA BIOMATERIALS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 62.CARPENTER TECHNOLOGY CORPORATION: COMPANY SNAPSHOT
- TABLE 63.CARPENTER TECHNOLOGY CORPORATION: OPERATING SEGMENTS
- TABLE 64.CARPENTER TECHNOLOGY CORPORATION: PRODUCT PORTFOLIO
- TABLE 65.CORBION N.V.: COMPANY SNAPSHOT
- TABLE 66.CORBION N.V.: OPERATING SEGMENTS
- TABLE 67.CORBION N.V.: PRODUCT PORTFOLIO
- TABLE 68.COVALON TECHNOLOGIES LTD.: COMPANY SNAPSHOT
- TABLE 69.COVALON TECHNOLOGIES LTD.: OPERATING SEGMENTS
- TABLE 70.COVALON TECHNOLOGIES LTD.: PRODUCT PORTFOLIO
- TABLE 71.EVONIK INDUSTRIES AG : COMPANY SNAPSHOT
- TABLE 72.EVONIK INDUSTRIES AG : OPERATING SEGMENTS
- TABLE 73.EVONIK INDUSTRIES AG : PRODUCT PORTFOLIO
- TABLE 74.EVONIK INDUSTRIES AG : KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 75.LINDEN CAPITAL PARTNERS: COMPANY SNAPSHOT
- TABLE 76.LINDEN CAPITAL PARTNERS: OPERATING SEGMENTS
- TABLE 77.LINDEN CAPITAL PARTNERS: PRODUCT PORTFOLIO
- TABLE 78.NOBLE BIOMATERIALS INC: COMPANY SNAPSHOT33
- TABLE 79.NOBLE BIOMATERIALS INC.: OPEARTING SEGMENTS
- TABLE 80.NOBLE BIOMATERIALS INC.: PRODUCT PORTFOLIO34
- TABLE 81.ROYAL DSM: COMPANY SNAPSHOT35
- TABLE 82.ROYAL DSM: PRODUCT SEGMENTS
- TABLE 83.ROYAL DSM: PRODUCT PORTFOLIO
- TABLE 84.ROYAL DSM: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 85.VICTREX PLC: COMPANY SNAPSHOT
- TABLE 86.VICTREX PLC: OPERATING SEGMENTS
- TABLE 87.VICTREX PLC: PRODUCT PORTFOLIO41
- TABLE 88.STRYKER: COMPANY SNAPSHOT
- TABLE 89.STRYKER: OPERATING SEGMENTS
- TABLE 90.STRYKER: PRODUCT PORTFOLIO
- TABLE 91.ZIMMER BIOMET: COMPANY SNAPSHOT
- TABLE 92.ZIMMER BIOMET: OPERATING SEGMENTS
- TABLE 93.ZIMMER BIOMET: PRODUCT PORTFOLIO
- LIST OF FIGURES
- FIGURE 1.GLOBAL BIOMATERIALS MARKET SEGMENTATION
- FIGURE 2.GLOBAL BIOMATERIALS MARKET
- FIGURE 3.SEGMENTATION BIOMATERIALS MARKET
- FIGURE 4.TOP INVESTMENT POCKET IN BIOMATERIALS MARKET
- FIGURE 5.TOP WINNING STRATEGIES, 2019-2021*
- FIGURE 6.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021(%)
- FIGURE 7.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021*
- FIGURE 8.MODERATE BARGAINING POWER OF BUYERS
- FIGURE 9.MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 10.MODERATE THREAT OF NEW ENTRANTS
- FIGURE 11.LOW THREAT OF SUBSTITUTION
- FIGURE 12.HIGH COMPETITIVE RIVALRY
- FIGURE 13.TOP PLAYER POSITIONING, 2020
- FIGURE 14.MARKET SHARE ANALYSIS, 2020
- FIGURE 15.RESTRAINTS AND DRIVERS: BIOMATERIALS MARKET
- FIGURE 16.BIOMATERIALS MARKET SEGMENTATION, BY TYPE
- FIGURE 17.BIOMATERIALS MARKET FOR METALLIC, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 18.BIOMATERIALS MARKET FOR POLYMERIC, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 19.BIOMATERIALS MARKET FOR CERAMIC, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 20.BIOMATERIALS MARKET FOR NATURAL, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 21.BIOMATERIALS MARKET SEGMENTATION, BY APPLICATION
- FIGURE 22.BIOMATERIALS MARKET FOR CARDIOVASCULAR, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 23.BIOMATERIALS MARKET FOR DENTAL, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 24.BIOMATERIALS MARKET FOR ORTHOPEDIC, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 25.BIOMATERIALS MARKET FOR WOUND HEALING, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 26.BIOMATERIALS MARKET FOR PLASTIC SURGERY, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 27.BIOMATERIALS MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 28.BIOMATERIALS MARKET FOR NEUROLOGICAL DISORDER, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 29.BIOMATERIALS MARKET FOR DRUG DELIVERY SYSTEM, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 01.CARPENTER TECHNOLOGY CORPORATION: NET SALES, 2019–2021 ($MILLION)
- FIGURE 02.CARPENTER TECHNOLOGY CORPORATION: REVENUE SHARE, BY SEGMENT, 2021 (%)
- FIGURE 03.CARPENTER TECHNOLOGY CORPORATION: REVENUE SHARE, BY REGION, 2021 (%)
- FIGURE 04.CORBION N.V.: NET SALES, 2018–2020 ($MILLION)
- FIGURE 05.CORBION N.V.: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 06.CORBION N.V.: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 07.COVALON TECHNOLOGIES LTD: NET SALES, 2019–2021 ($MILLION)
- FIGURE 08.COVALON TECHNOLOGIES LTD: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 09.EVONIK INDUSTRIES AG : NET SALES, 2018–2020 ($MILLION)
- FIGURE 10.EVONIK INDUSTRIES AG : REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 11.EVONIK INDUSTRIES AG : REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 12.ROYAL DSM: NET SALES, 2018–2020($MILLION)
- FIGURE 13.ROYAL DSM: REVENUE SHARE, BY SEGMENTS, 2020 (%)
- FIGURE 14.ROYAL DSM: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 15.VICTREX PLC: NET SALES, 2019–2021 ($MILLION)
- FIGURE 16.VICTREX PLC: REVENUE SHARE, BY SEGMENT, 2021 (%)
- FIGURE 17.VICTREX PLC: REVENUE SHARE, BY REGION, 2021 (%)
- FIGURE 18.STRYKER: NET SALES, 2018–2020 ($MILLION)
- FIGURE 19.STRYKER: REVENUE SHARE BY SEGMENT, 2020 (%)
- FIGURE 20.STRYKER: REVENUE SHARE BY REGION, 2020 (%)
- FIGURE 21.ZIMMER BIOMET: NET SALES, 2018–2020 ($MILLION)
- FIGURE 22.ZIMMER BIOMET: REVENUE SHARE BY SEGMENT, 2020 (%)
- FIGURE 23.ZIMMER BIOMET: REVENUE SHARE BY REGION, 2020 (%)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook